Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf

Overview of attention for article published in BMC Cancer, March 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Fighting Melanoma, 26 Mar 2019

Our data suggests that the PDE8A-C-Raf complex is a promising therapeutic treatment for B-Raf inhibitor resistant melanoma.

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.